GRID radiotherapy

RADIATION2 trials

Sponsors

University Hospital, Ghent, University of Arkansas

Conditions

Head and Neck TumorsOsteosarcoma in ChildrenRadiation Toxicity

Phase 1

Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area

TerminatedNCT00528294

University Hospital, GhentHead and Neck Tumors

Start: 2007-02-28End: 2015-09-30Target: 12Updated: 2022-12-20

Unknown Phase

Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity

TerminatedNCT03139318

University of ArkansasOsteosarcoma in Children, Radiation Toxicity

Start: 2017-07-25End: 2018-08-29Updated: 2022-07-20